PATENT CLAIM ANALYSIS

Application Number: 15877598
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-06
Patent Classification: ["424", "191100"]

Abstract:
Vaccine vectors and methods of using the vaccine vectors to enhance the immune response to an Apicomplexan parasite and reduce the morbidity or mortality associated with subsequent infection are provided herein. The vaccine vectors include a polynucleotide encoding a Rhomboid polypeptide and optionally include an immune-stimulatory polypeptide suitably expressed on the surface of the vaccine vector.

Claim (Index 4):
The vaccine vector of  claim 3 , wherein the HMGB1 polypeptide comprises a polypeptide selected from the group consisting of SEQ ID NOs: 15-23, a polypeptide having at least 95% sequence identity to SEQ ID NO: 15-23 and combinations thereof.

Metadata:
- Claim Count in Document: 23.0
- Percentile: 86.0
- Lexical Diversity: 1.41463
- Patent Class: 424.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14768011', '12740608', '14623050', '14776986', '13574504']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7991462645329095
- 35 USC 102 Novelty (BERT): 0.578572795922216
- Combined Prediction Score: 0.7770889176718402
- Mean Citation Score: 355.638482
- Max Citation Score: 459.58566
- Similarity Product: 458.0105919864106

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test